tradingkey.logo

Globus Medical Inc

GMED

71.580USD

-0.189-0.26%
Market hours ETQuotes delayed by 15 min
9.84BMarket Cap
95.52P/E TTM

Globus Medical Inc

71.580

-0.189-0.26%
More Details of Globus Medical Inc Company
Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions with a focus on improving the quality of life of patients with musculoskeletal disorders. The Company offers a portfolio of differentiated technologies that are used to treat a variety of musculoskeletal conditions. Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in a range of spinal, orthopedic and neurosurgical procedures. Its spine products address the conditions affecting the spine, including degenerative conditions, deformities, tumors, and trauma. It provides solutions that facilitate both open and minimally invasive surgery techniques. It includes traditional fusion implants, such as pedicle screws and rod systems, and others. Its orthopedic trauma solutions are designed to treat a variety of orthopedic fracture patterns and patient anatomies in the upper and lower extremities, as well as the hip.
Company Info
Company codeGMED
Company nameGlobus Medical Inc
IPO dateMar 08, 2012
Founded at2003
CEOMr. Daniel T. (Dan) Scavilla
Number of employees5300
Security typeOrdinary Share
Fiscal year-endMar 08
Address2560 General Armistead Ave
CityAUDUBON
Stock exchangeNYSE Consolidated
CountryUnited States of America
Postal code19403
Phone16109301800
Websitehttps://www.globusmedical.com/
Company codeGMED
IPO dateMar 08, 2012
Founded at2003
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. David D. Davidar
Mr. David D. Davidar
Independent Director
Independent Director
685.24K
-6.86%
Ms. Ann D. Rhoads
Ms. Ann D. Rhoads
Independent Director
Independent Director
35.38K
--
Mr. Daniel J. Wolterman
Mr. Daniel J. Wolterman
Independent Director
Independent Director
24.02K
--
Ms. Leslie V. Norwalk
Ms. Leslie V. Norwalk
Independent Director
Independent Director
16.42K
--
Mr. Robert Andrew (Rob) Douglas
Mr. Robert Andrew (Rob) Douglas
Independent Director
Independent Director
2.00K
--
Mr. Brian Kearns
Mr. Brian Kearns
Investor Relations
Investor Relations
--
--
Mr. Stephen T. (Steve) Zarrilli
Mr. Stephen T. (Steve) Zarrilli
Independent Director
Independent Director
--
--
Mr. James R. Tobin
Mr. James R. Tobin
Independent Director
Independent Director
--
--
Ms. Kelly Grace Huller, J.D.
Ms. Kelly Grace Huller, J.D.
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
--
--
Mr. Daniel T. (Dan) Scavilla
Mr. Daniel T. (Dan) Scavilla
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. David D. Davidar
Mr. David D. Davidar
Independent Director
Independent Director
685.24K
-6.86%
Ms. Ann D. Rhoads
Ms. Ann D. Rhoads
Independent Director
Independent Director
35.38K
--
Mr. Daniel J. Wolterman
Mr. Daniel J. Wolterman
Independent Director
Independent Director
24.02K
--
Ms. Leslie V. Norwalk
Ms. Leslie V. Norwalk
Independent Director
Independent Director
16.42K
--
Mr. Robert Andrew (Rob) Douglas
Mr. Robert Andrew (Rob) Douglas
Independent Director
Independent Director
2.00K
--
Mr. Brian Kearns
Mr. Brian Kearns
Investor Relations
Investor Relations
--
--
Revenue Breakdown
Currency: USDUpdate time: Sun, Apr 6
Currency: USDUpdate time: Sun, Apr 6
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Musculoskeletal Solutions products
2.37B
93.89%
Enabling Technologies products
154.00M
6.11%
By RegionUSD
Name
Revenue
Proportion
United States
2.00B
79.39%
International
519.29M
20.61%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Musculoskeletal Solutions products
2.37B
93.89%
Enabling Technologies products
154.00M
6.11%
Shareholder
Update time: Fri, Feb 21
Update time: Fri, Feb 21
Shareholder Statistics
Type
Shareholder Statistics
Shareholder
Proportion
The Vanguard Group, Inc.
9.60%
BlackRock Institutional Trust Company, N.A.
8.72%
Janus Henderson Investors
5.86%
State Street Global Advisors (US)
3.18%
JP Morgan Asset Management
2.32%
Other
70.32%
Shareholder Statistics
Shareholder
Proportion
The Vanguard Group, Inc.
9.60%
BlackRock Institutional Trust Company, N.A.
8.72%
Janus Henderson Investors
5.86%
State Street Global Advisors (US)
3.18%
JP Morgan Asset Management
2.32%
Other
70.32%
Type
Shareholder
Proportion
Investment Advisor/Hedge Fund
41.80%
Investment Advisor
40.95%
Hedge Fund
11.08%
Pension Fund
2.17%
Sovereign Wealth Fund
1.33%
Bank and Trust
1.08%
Research Firm
1.00%
Individual Investor
0.69%
Venture Capital
0.22%
Institutional Shareholding
Update time: Mon, Jan 20
Update time: Mon, Jan 20
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q1
1002
114.23M
101.23%
-9.79M
2024Q4
1031
113.94M
83.15%
-12.71M
2024Q3
978
112.33M
98.84%
-21.04M
2024Q2
969
117.21M
103.71%
-15.66M
2024Q1
950
117.87M
104.30%
-9.50M
2023Q4
917
111.19M
96.81%
-13.25M
2023Q3
911
113.44M
96.67%
+12.22M
2023Q2
864
84.90M
108.73%
-4.84M
2023Q1
857
78.38M
100.58%
-6.61M
2022Q4
815
79.68M
102.42%
-5.05M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
10.84M
9.42%
+239.15K
+2.26%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
9.84M
8.55%
+310.21K
+3.25%
Dec 31, 2024
Janus Henderson Investors
6.61M
5.75%
-382.86K
-5.47%
Dec 31, 2024
State Street Global Advisors (US)
3.59M
3.12%
+23.74K
+0.66%
Dec 31, 2024
JP Morgan Asset Management
2.62M
2.28%
+190.79K
+7.84%
Dec 31, 2024
Burgundy Asset Management Ltd.
2.62M
2.27%
+43.33K
+1.68%
Dec 31, 2024
Citadel Advisors LLC
2.57M
2.23%
+985.04K
+62.08%
Dec 31, 2024
Wellington Management Company, LLP
2.50M
2.17%
-81.89K
-3.18%
Dec 31, 2024
Sculptor Capital Management, Inc
2.08M
1.81%
-132.90K
-6.01%
Dec 31, 2024
Geode Capital Management, L.L.C.
1.90M
1.65%
+12.15K
+0.64%
Dec 31, 2024
View more
Related ETFs
Update time: Sun, Apr 6
Update time: Sun, Apr 6
Name
Proportion
Motley Fool Mid-Cap Growth ETF
4.77%
Motley Fool Small-Cap Growth ETF
4.47%
First Trust Nasdaq Lux Digi Health Solutions ETF
4.12%
ERShares Entrepreneurs ETF
2.19%
Alpha Architect U.S. Quantitative Momentum ETF
1.92%
Invesco S&P MidCap 400 Pure Growth ETF
1.85%
SPDR S&P Health Care Equipment ETF
1.57%
First Trust Indxx Medical Devices ETF
1.53%
ROBO Global Healthcare Technology & Innovation ETF
1.12%
ROBO Global Robotics and Automation Index ETF
1.11%
View more
Motley Fool Mid-Cap Growth ETF
Proportion4.77%
Motley Fool Small-Cap Growth ETF
Proportion4.47%
First Trust Nasdaq Lux Digi Health Solutions ETF
Proportion4.12%
ERShares Entrepreneurs ETF
Proportion2.19%
Alpha Architect U.S. Quantitative Momentum ETF
Proportion1.92%
Invesco S&P MidCap 400 Pure Growth ETF
Proportion1.85%
SPDR S&P Health Care Equipment ETF
Proportion1.57%
First Trust Indxx Medical Devices ETF
Proportion1.53%
ROBO Global Healthcare Technology & Innovation ETF
Proportion1.12%
ROBO Global Robotics and Automation Index ETF
Proportion1.11%
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data